International Biotechnology Trust PLC Spring Works Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$18.36 - $60.07 $291,905 - $955,052	-15,899 Reduced 97.54%	401 $16.3 Million
Q1 2022 May 20, 2022	SELL	$48.97 - $65.46 $426,039 - $569,502	-8,700 Reduced 34.8%	16,300 $919,000
Q3 2021 Nov 12, 2021	BUY	$62.66 - $88.26 $1.57 Million - $2.21 Million	25,000 New	25,000 $1.58 Million

241

70.1M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $3.44B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.